FI800205A7 - Hiilihappoanhydraasi-inhibiittoreita ja S-(-)-l-(tert-butyyli- amino)-3-/(morfolino-1,2,5-tiadiatsol-3-yyli)okyyli)oksi/-2-propanolia sisältäviä silmälääkekoostumuksia kohonneen sisilmänsisäisen paineen paikalliseen käsittelyyn. - Google Patents

Hiilihappoanhydraasi-inhibiittoreita ja S-(-)-l-(tert-butyyli- amino)-3-/(morfolino-1,2,5-tiadiatsol-3-yyli)okyyli)oksi/-2-propanolia sisältäviä silmälääkekoostumuksia kohonneen sisilmänsisäisen paineen paikalliseen käsittelyyn. Download PDF

Info

Publication number
FI800205A7
FI800205A7 FI800205A FI800205A FI800205A7 FI 800205 A7 FI800205 A7 FI 800205A7 FI 800205 A FI800205 A FI 800205A FI 800205 A FI800205 A FI 800205A FI 800205 A7 FI800205 A7 FI 800205A7
Authority
FI
Finland
Prior art keywords
thiadiazol
butylamino
morpholino
oxy
propanol
Prior art date
Application number
FI800205A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Robert Lawrence Smith
Ralph F Hirschmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI800205A7 publication Critical patent/FI800205A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI800205A 1979-02-02 1980-01-24 Hiilihappoanhydraasi-inhibiittoreita ja S-(-)-l-(tert-butyyli- amino)-3-/(morfolino-1,2,5-tiadiatsol-3-yyli)okyyli)oksi/-2-propanolia sisältäviä silmälääkekoostumuksia kohonneen sisilmänsisäisen paineen paikalliseen käsittelyyn. FI800205A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US890379A 1979-02-02 1979-02-02

Publications (1)

Publication Number Publication Date
FI800205A7 true FI800205A7 (fi) 1981-01-01

Family

ID=21734364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800205A FI800205A7 (fi) 1979-02-02 1980-01-24 Hiilihappoanhydraasi-inhibiittoreita ja S-(-)-l-(tert-butyyli- amino)-3-/(morfolino-1,2,5-tiadiatsol-3-yyli)okyyli)oksi/-2-propanolia sisältäviä silmälääkekoostumuksia kohonneen sisilmänsisäisen paineen paikalliseen käsittelyyn.

Country Status (9)

Country Link
EP (1) EP0014642B1 (enExample)
JP (1) JPS55122716A (enExample)
AT (1) ATE6738T1 (enExample)
AU (1) AU536438B2 (enExample)
DE (1) DE3067081D1 (enExample)
DK (1) DK43280A (enExample)
FI (1) FI800205A7 (enExample)
IE (1) IE49507B1 (enExample)
NZ (1) NZ192673A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
EP1507513A1 (de) * 2002-05-24 2005-02-23 Dr. GERHARD MANN chem.-pharm. Fabrik GmbH Tropfbares ophthalmisches gelpräparat mit diclofenamid und timolol
EP2847175A4 (en) * 2012-05-08 2016-04-20 Cellix Bio Private Ltd COMPOSITIONS AND METHODS INHIBITING THE ACTIVITY OF CARBONIC ANHYDRASE
KR101698163B1 (ko) * 2014-12-19 2017-01-19 동아에스티 주식회사 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860371A (en) * 1958-07-03 1961-02-01 Pfizer & Co C Di-sulfonamides and compositions containing them
NL7508856A (nl) * 1974-08-16 1976-02-18 Merck & Co Inc Werkwijze voor het bereiden van preparaten tegen hypertensie.
NZ182022A (en) * 1975-09-26 1978-12-18 Merck & Co Inc Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls

Also Published As

Publication number Publication date
IE800207L (en) 1980-08-02
DK43280A (da) 1980-08-03
EP0014642A2 (en) 1980-08-20
ATE6738T1 (de) 1984-04-15
AU5487980A (en) 1980-08-07
AU536438B2 (en) 1984-05-10
IE49507B1 (en) 1985-10-16
NZ192673A (en) 1984-07-06
EP0014642A3 (en) 1981-01-07
EP0014642B1 (en) 1984-03-21
DE3067081D1 (en) 1984-04-26
JPS55122716A (enExample) 1980-09-20

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
NZ183416A (en) Composition for enzymatic treatment of cataract
DE3071202D1 (en) Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them
NO157146C (no) Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin.
SE7804307L (sv) Forfarande for framstellning av 2-(2,2-diarylalkyl)-1-azabicyklo(2.2.2)oktan och beslektade foreningar
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
DK319676A (da) 2',3,6'-trichlor-4-cyano-4'-benzoylureido-diphenylethere, fremgangsmade til deres fremstilling og deres anvendelse som insecticider
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
SE7801199L (sv) N-substituerade halogenacetanilider till anvendning som herbicider och sett att framstella foreningarna
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
FI800205A7 (fi) Hiilihappoanhydraasi-inhibiittoreita ja S-(-)-l-(tert-butyyli- amino)-3-/(morfolino-1,2,5-tiadiatsol-3-yyli)okyyli)oksi/-2-propanolia sisältäviä silmälääkekoostumuksia kohonneen sisilmänsisäisen paineen paikalliseen käsittelyyn.
DE3068383D1 (en) Novel sulfonamides, compositions containing them, and methods for controlling the growth of undesired vegetation using them
FI800089A7 (fi) Viherkaihin hoitoon tarkoitettuja valmisteita.
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
SE7910554L (sv) Disulfidforeningar
NO159532C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 1-(4-kinolyl)-2-(4-piperidyl)-etanol eller1-(4-kinolyl)-3-(4-piperidyl)-propanol.
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
DK410375A (da) 4-stilbenyl-1,2,3-triazoler samt fremgangsmader til disses fremstilling og anvendelse som optiske klaringsmidler
FI802910A7 (fi) Silmämikroskoopin valokoagulaattori.
NO153848C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(arylthioalkyl)-n[-(aminoalkyl)-ureaderivater.
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
IE39714B1 (en) N-/2-(5-nitro-1imidazolyl)ethyl/carbamates
FI842101A7 (fi) Farmaseuttinen silmälääkekoostumus kohonneen silmänsisäisen paineen paikalliseen käsittelyyn.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MERCK & CO INC.